Shanghai, April 10, 2026 – The 93rd China International Medical Equipment Fair (CMEF) kicked off at the National Exhibition and Convention Center, gathering nearly 5,000 brands from more than 20 countries and regions to showcase cutting-edge clinical medical equipment and innovative solutions. This year’s exhibition, covering over 320,000 square meters, has become a global platform for displaying the latest technological achievements in the field, highlighting the integration of artificial intelligence (AI), robotics, and digital technology with clinical medical equipment, and accelerating the transformation of precision healthcare.
Among the highlights, GE Healthcare made a strong presence with more than 50 precision medical innovations, including 12 first-launch products and 11 new clinical application solutions. Over 60% of the exhibits were independently developed by the Chinese team, and 95% were manufactured in China, all of which integrated AI and other digital technologies. Focusing on the challenges of aging-related chronic diseases and severe illness burdens, GE Healthcare has upgraded its innovation focus to disease-integrated solutions covering the entire path of "screening, diagnosis, treatment, follow-up, and management," aiming to achieve earlier disease detection and more precise diagnosis and treatment.
SINOMED, a leading domestic medical equipment enterprise, also unveiled a series of pioneering products at the exhibition. Its newly launched full-spherical stereotactic radiotherapy system, a revolutionary medical linear accelerator designed for global high-end cancer treatment centers, breaks the two-dimensional movement limitations of traditional radiotherapy equipment and realizes precise treatment in three-dimensional space. With a full-spherical motion design, the device replaces traditional treatment table movement with treatment head swing in non-coplanar radiation therapy, fundamentally changing the traditional radiotherapy mode. Scheduled to be put into use in 2027, it can perform stereotactic radiosurgery on the head and is equipped with variable SAD core technology to improve treatment accuracy and reduce field penumbra.
In the field of minimally invasive medical robots, a domestically developed new-generation minimally invasive diagnosis and treatment robot, which obtained the Class III medical device registration certificate from the National Medical Products Administration in late February 2026, made its debut at the exhibition. Integrating AI navigation, 3D image reconstruction, and flexible robotic arms, the robot achieves sub-millimeter precision positioning, automatically adapts to patients’ respiratory movement and body position changes, and real-time corrects operational deviations. Clinical data shows that it significantly improves the success rate of one-time surgery, reduces the risk of complications, and simultaneously decreases intraoperative blood loss and radiation dose. Its modular design and lightweight body make it suitable for both complex surgeries in top-tier hospitals and rapid deployment in primary medical institutions.
Overseas enterprises also brought new breakthroughs. Royal Philips launched its intuitive interventional guidance platform, IntraSight Plus, which has obtained CE mark and FDA 510(k) clearance and is now available in the U.S. and European markets. The redesigned platform integrates comprehensive diagnostic and treatment planning tools into a single intuitive system, enabling clinicians to diagnose, virtually plan treatment, guide device placement, and verify results on one screen, which can save up to 47% of system operation time and enhance workflow efficiency in catheterization labs.
In addition to hardware innovations, the integration of digital technologies such as AI and extended reality (AR/VR) has become a key trend in the development of clinical medical equipment. According to the U.S. Food and Drug Administration (FDA), AR/VR technologies are transforming healthcare by providing immersive and personalized diagnostic and treatment solutions, such as AR systems that overlay medical images on patients during surgery to guide surgeons, and VR rehabilitation therapies that simulate real-life scenarios to help stroke patients recover physical functions. Meanwhile, the FDA recently approved Neurolief’s Proliv™ RX, the first wearable at-home brain neuromodulation device for treating major depressive disorder in adults who have not responded to at least one antidepressant, marking a major breakthrough in home-based clinical treatment equipment.
Industry experts pointed out that the continuous innovation of clinical medical equipment is driven by the growing global health demand and technological progress. While remarkable achievements have been made in domestic high-end medical equipment localization and intelligent transformation, there are still gaps in some core components and technical standards. Looking ahead, with the deep integration of emerging technologies such as quantum computing and nanotechnology with the medical equipment field, clinical medical equipment will move towards higher precision, intelligence, and accessibility, further promoting the balanced allocation of medical resources and improving the quality of global healthcare services.